Related Experiment Video
Updated: May 10, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Thrombin inhibition by the serpins.
1Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK. jah52@cam.ac.uk
Four serpins (AT, PCI, HCII, PN1) inhibit thrombin, the central protease in blood coagulation. This review details how these serpins uniquely recognize thrombin using cofactors for effective inhibition.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Thrombin is a key protease in blood coagulation, regulating hemostasis and thrombosis.
- Four distinct serpins, including antithrombin (AT), protein C inhibitor (PCI), heparin cofactor II (HCII), and protease nexin-1 (PN1), are known to inhibit thrombin.
- Structural insights over the past decade have elucidated the mechanisms of thrombin-serpin recognition, often mediated by cofactors.
Purpose of the Study:
- To review the structural features of thrombin involved in substrate and cofactor recognition.
- To discuss the common serpin mechanism of protease inhibition.
- To explore how four specific thrombin-binding serpins utilize thrombin's unique characteristics and cofactors to accelerate complex formation in diverse physiological environments.
Main Methods:
- Review of structural biology studies on thrombin and serpin interactions.
- Analysis of cofactor-dependent recognition mechanisms.
- Discussion of thrombin's role in complex formation with its inhibitors.
Main Results:
- Thrombin possesses unusual structural features critical for recognizing both substrates and cofactors.
- Despite a shared inhibitory fold, the four thrombin-specific serpins exhibit distinct cofactor-assisted recognition strategies.
- These varied recognition mechanisms are adapted to the different biological contexts in which thrombin functions.
Conclusions:
- The diverse environments of thrombin necessitate specialized recognition mechanisms by its inhibitory serpins.
- Structural adaptations in thrombin facilitate differential recognition by AT, PCI, HCII, and PN1.
- Understanding these interactions is crucial for comprehending blood coagulation and developing targeted therapies.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

